| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.38e-05 | 149 | 105 | 7 | GO:1990782 | |
| GeneOntologyCellularComponent | cell leading edge | MPP2 JCAD ERBB2 SORBS2 ATN1 MYO9B PSTPIP1 BCAR1 SH2B1 NEDD9 PAFAH1B1 MTMR9 | 1.42e-05 | 500 | 111 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | anchoring junction | MPP2 JCAD SORBS2 ATN1 ANK3 PARD3B PANX2 BCAR1 YES1 PRAG1 ZAP70 NEDD9 TJP2 ILDR1 CTNND2 MMP14 PCBP2 | 1.51e-05 | 976 | 111 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | cell cortex | ARHGAP32 MYO9B PARD3B PSTPIP1 NEDD9 FRY GYS2 PAFAH1B1 MICAL3 BSN | 2.89e-05 | 371 | 111 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | DOK1 JCAD ERBB2 SORBS2 ATN1 MYO9B PSTPIP1 IRAG1 PRR7 MAP1S PAFAH1B1 SEC16A CACNA1G BANK1 DDX4 MTMR9 | 3.37e-05 | 934 | 111 | 16 | GO:0048471 |
| Domain | SH3 | MPP2 DOCK4 ARHGAP32 SORBS2 PSTPIP1 BCAR1 YES1 NEDD9 SASH3 TJP2 | 5.02e-07 | 216 | 108 | 10 | SM00326 |
| Domain | SH3 | MPP2 DOCK4 ARHGAP32 SORBS2 PSTPIP1 BCAR1 YES1 NEDD9 SASH3 TJP2 | 5.02e-07 | 216 | 108 | 10 | PS50002 |
| Domain | SH3_domain | MPP2 DOCK4 ARHGAP32 SORBS2 PSTPIP1 BCAR1 YES1 NEDD9 SASH3 TJP2 | 5.93e-07 | 220 | 108 | 10 | IPR001452 |
| Domain | LRRC37AB_C | 7.49e-07 | 4 | 108 | 3 | PF14914 | |
| Domain | LRRC37_N | 7.49e-07 | 4 | 108 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 7.49e-07 | 4 | 108 | 3 | IPR029423 | |
| Domain | LRRC37 | 7.49e-07 | 4 | 108 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 7.49e-07 | 4 | 108 | 3 | IPR015753 | |
| Domain | Med13_N | 3.31e-05 | 2 | 108 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 3.31e-05 | 2 | 108 | 2 | IPR021643 | |
| Domain | Mediator_Med13 | 3.31e-05 | 2 | 108 | 2 | IPR009401 | |
| Domain | Med13_C | 3.31e-05 | 2 | 108 | 2 | PF06333 | |
| Domain | Serine_rich | 9.90e-05 | 3 | 108 | 2 | IPR014928 | |
| Domain | Serine_rich | 9.90e-05 | 3 | 108 | 2 | PF08824 | |
| Domain | SH3_2 | 1.41e-04 | 86 | 108 | 5 | IPR011511 | |
| Domain | SH3_2 | 1.41e-04 | 86 | 108 | 5 | PF07653 | |
| Domain | DUF3513 | 1.97e-04 | 4 | 108 | 2 | PF12026 | |
| Domain | CAS_DUF3513 | 1.97e-04 | 4 | 108 | 2 | IPR021901 | |
| Domain | SH3_1 | 3.82e-04 | 164 | 108 | 6 | PF00018 | |
| Domain | TLV_coat | 6.83e-04 | 7 | 108 | 2 | PF00429 | |
| Domain | TLV/ENV_coat_polyprotein | 9.07e-04 | 8 | 108 | 2 | IPR018154 | |
| Domain | SH3_9 | 1.09e-03 | 78 | 108 | 4 | PF14604 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | JCAD ARHGAP32 MAGEL2 ATN1 ANK3 BCAR1 YES1 SH2B1 PRR7 NEDD9 NCOR2 MAP1S BSN | 1.32e-09 | 430 | 111 | 13 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 ERBB2 KIF26A MYO9B PER1 MED13L PRAG1 FAM83H NCOR2 MAP1S EIF4G1 SEC16A ZFYVE26 MICAL3 MMP14 HECTD1 PLXNA1 MED13 | 1.39e-08 | 1105 | 111 | 18 | 35748872 |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 4.01e-08 | 102 | 111 | 7 | 15778465 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 22419166 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 JCAD ARHGAP32 ERBB2 SORBS2 PARD3B BCAR1 PRAG1 FAM83H FSIP2 EIF4G1 SEC16A TJP2 HECTD1 | 6.67e-07 | 861 | 111 | 14 | 36931259 |
| Pubmed | ARHGAP32 ERBB2 ANK3 MARK1 PARD3B PLEKHA6 YES1 JPH1 SEC16A MICAL3 | 1.06e-06 | 421 | 111 | 10 | 36976175 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 23064749 | ||
| Pubmed | ARHGAP32 DMXL2 MARK1 DHX38 RNF8 PER1 PLEKHA6 SH2B1 MICAL3 HECTD1 | 4.30e-06 | 493 | 111 | 10 | 15368895 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23605953 | ||
| Pubmed | The clinical significance of small copy number variants in neurodevelopmental disorders. | 1.01e-05 | 2 | 111 | 2 | 25106414 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 25241893 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18164686 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 25205731 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18826608 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19058300 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23555306 | ||
| Pubmed | YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancers. | 1.01e-05 | 2 | 111 | 2 | 31856375 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 29325037 | ||
| Pubmed | p130Cas is an essential transducer element in ErbB2 transformation. | 1.01e-05 | 2 | 111 | 2 | 20505116 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17051526 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23839042 | ||
| Pubmed | 1.40e-05 | 15 | 111 | 3 | 16601135 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | JCAD ARHGAP32 ERBB2 ANK3 PLEKHA6 FAM83H EIF4G1 TJP2 EIF2A PCBP2 | 1.40e-05 | 565 | 111 | 10 | 25468996 |
| Pubmed | MPP2 DOCK4 JCAD ARHGAP32 DMXL2 SORBS2 ANK3 MARK1 PER1 PANX2 MAP1S TJP2 CTNND2 BSN | 1.65e-05 | 1139 | 111 | 14 | 36417873 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.98e-05 | 588 | 111 | 10 | 38580884 | |
| Pubmed | Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. | 3.02e-05 | 3 | 111 | 2 | 17852076 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 29934494 | ||
| Pubmed | Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion. | 3.02e-05 | 3 | 111 | 2 | 28442738 | |
| Pubmed | NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis. | 3.02e-05 | 3 | 111 | 2 | 24202705 | |
| Pubmed | The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. | 3.02e-05 | 3 | 111 | 2 | 12517963 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 19270645 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 21765937 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 9049630 | ||
| Pubmed | JCAD ARHGAP32 LRRC37A3 MUC16 SMOC2 NCOR2 ASXL3 AGK CTNND2 BSN | 3.94e-05 | 638 | 111 | 10 | 31182584 | |
| Pubmed | NRG1 signalling regulates the establishment of Sertoli cell stock in the mouse testis. | 4.04e-05 | 21 | 111 | 3 | 30040984 | |
| Pubmed | MPP2 ARHGAP32 DMXL2 SORBS2 ANK3 MARK1 PLEKHA6 MAP1S PAFAH1B1 EIF4G1 SEC16A TJP2 MICAL3 CTNND2 BSN | 5.08e-05 | 1431 | 111 | 15 | 37142655 | |
| Pubmed | 5.35e-05 | 23 | 111 | 3 | 22792062 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 5.76e-05 | 536 | 111 | 9 | 15840001 | |
| Pubmed | 5.93e-05 | 538 | 111 | 9 | 10512203 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 14566828 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 14612387 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 8668148 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 20961652 | ||
| Pubmed | Nephrocystin-1 interacts directly with Ack1 and is expressed in human collecting duct. | 6.03e-05 | 4 | 111 | 2 | 18477472 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9366405 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9748319 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 29809150 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9498705 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9295052 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 26716506 | ||
| Pubmed | TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. | 6.03e-05 | 4 | 111 | 2 | 26899482 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9360983 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 10332026 | ||
| Pubmed | MPP2 ARHGAP32 DMXL2 SORBS2 ANK3 NHSL2 NCOR2 FRY EIF4G1 SEC16A CTNND2 BSN | 6.07e-05 | 963 | 111 | 12 | 28671696 | |
| Pubmed | JCAD DMXL2 SORBS2 ANK3 MED13L SH2B1 JPH1 FRY MAP1S RALBP1 EIF4G1 CTNND2 HECTD1 MED13 | 6.13e-05 | 1285 | 111 | 14 | 35914814 | |
| Pubmed | 6.30e-05 | 130 | 111 | 5 | 12421765 | ||
| Pubmed | 7.02e-05 | 133 | 111 | 5 | 15144186 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ARHGAP32 ATN1 MYO9B MUC16 PCDHA1 PLEKHA6 PSTPIP1 ASXL3 MICAL3 | 7.21e-05 | 552 | 111 | 9 | 10737800 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 JCAD ARHGAP32 PARD3B YES1 FAM83H TJP2 MICAL3 EIF2A PCBP2 MTMR9 | 9.25e-05 | 853 | 111 | 11 | 28718761 |
| Pubmed | PALD1 ARHGAP32 ERBB2 ANK3 JPH1 EIF4G1 SEC16A AGK MICAL3 EIF2A | 9.33e-05 | 708 | 111 | 10 | 39231216 | |
| Pubmed | 9.85e-05 | 332 | 111 | 7 | 37433992 | ||
| Pubmed | 1.00e-04 | 75 | 111 | 4 | 15951569 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 23640898 | ||
| Pubmed | Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. | 1.00e-04 | 5 | 111 | 2 | 21034468 | |
| Pubmed | Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex. | 1.00e-04 | 5 | 111 | 2 | 16002533 | |
| Pubmed | Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. | 1.00e-04 | 5 | 111 | 2 | 10502414 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.02e-04 | 231 | 111 | 6 | 16452087 | |
| Pubmed | 1.11e-04 | 77 | 111 | 4 | 22973453 | ||
| Pubmed | ERBB2 DMXL2 MARK1 RIOK3 YES1 PAFAH1B1 TPSG1 MMP14 PLXNA1 MTMR9 | 1.20e-04 | 730 | 111 | 10 | 34857952 | |
| Pubmed | Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. | 1.21e-04 | 30 | 111 | 3 | 12522270 | |
| Pubmed | 1.29e-04 | 80 | 111 | 4 | 16094384 | ||
| Pubmed | 1.47e-04 | 32 | 111 | 3 | 22974441 | ||
| Pubmed | The mouse kinome: discovery and comparative genomics of all mouse protein kinases. | 1.50e-04 | 6 | 111 | 2 | 15289607 | |
| Pubmed | Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways. | 1.50e-04 | 6 | 111 | 2 | 10692442 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 23085571 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 15003627 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 11278335 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 10936052 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 20561531 | ||
| Pubmed | 1.60e-04 | 251 | 111 | 6 | 27507650 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNL2 F2RL3 MARK1 BCAR1 YES1 PRAG1 FAM83H NCOR2 MAP1S RALBP1 EIF4G1 | 1.63e-04 | 910 | 111 | 11 | 36736316 |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 2.03e-04 | 90 | 111 | 4 | 16273093 | |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 2.10e-04 | 7 | 111 | 2 | 16481466 | |
| Pubmed | Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. | 2.10e-04 | 7 | 111 | 2 | 16107726 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 12093747 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 9020138 | ||
| Pubmed | CMS: an adapter molecule involved in cytoskeletal rearrangements. | 2.10e-04 | 7 | 111 | 2 | 10339567 | |
| Pubmed | Steroidogenic Factor 1 (Nr5a1) is Required for Sertoli Cell Survival Post Sex Determination. | 2.10e-04 | 7 | 111 | 2 | 30872705 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.10e-04 | 168 | 111 | 5 | 30631154 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.15e-04 | 265 | 111 | 6 | 19240061 | |
| Pubmed | 2.48e-04 | 513 | 111 | 8 | 25798074 | ||
| Pubmed | 2.66e-04 | 39 | 111 | 3 | 22802532 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 20442405 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 29662228 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 16425238 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 33504453 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.89e-04 | 180 | 111 | 5 | 35198878 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.94e-04 | 281 | 111 | 6 | 28706196 | |
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 20011118 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 23866081 | ||
| Interaction | CRKL interactions | DOK1 ARHGAP32 ERBB2 MAGEL2 ETV6 BCAR1 YES1 PRAG1 ZAP70 NEDD9 | 4.73e-07 | 227 | 110 | 10 | int:CRKL |
| Interaction | NCK2 interactions | DOK1 ARHGAP32 ERBB2 SORBS2 ATN1 NHSL2 BCAR1 FAM83H TJP2 NR5A1 | 1.74e-06 | 262 | 110 | 10 | int:NCK2 |
| Interaction | ABL1 interactions | 1.25e-05 | 259 | 110 | 9 | int:ABL1 | |
| Interaction | CDH1 interactions | JCAD ARHGAP32 ERBB2 ANK3 PLEKHA6 BCAR1 YES1 FAM83H NEDD9 EIF4G1 TJP2 CTNND2 EIF2A PCBP2 HECTD1 | 1.84e-05 | 768 | 110 | 15 | int:CDH1 |
| Interaction | SLC7A4 interactions | 2.95e-05 | 2 | 110 | 2 | int:SLC7A4 | |
| Interaction | LCK interactions | DOK1 ARHGAP32 ERBB2 ANK3 PLEKHA6 BCAR1 YES1 ZAP70 JPH1 NEDD9 CTNND2 | 4.61e-05 | 463 | 110 | 11 | int:LCK |
| Interaction | PTK2B interactions | 4.85e-05 | 119 | 110 | 6 | int:PTK2B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 5.17e-05 | 164 | 111 | 5 | chr6q25 | |
| Cytoband | 8q21 | 3.76e-04 | 12 | 111 | 2 | 8q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.06e-03 | 473 | 111 | 6 | chr17q21 | |
| Cytoband | 17q21.31 | 1.06e-03 | 82 | 111 | 3 | 17q21.31 | |
| Cytoband | 5p15.2 | 1.95e-03 | 27 | 111 | 2 | 5p15.2 | |
| GeneFamily | Cas scaffolding proteins | 8.08e-05 | 4 | 67 | 2 | 469 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.03e-06 | 199 | 110 | 8 | M5893 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 ANK3 MARK1 MYT1 PLEKHA6 MED13L PXK JPH1 FSIP2 FRY ASXL3 DACT3 MICAL3 CACNA1G CTNND2 BSN PLXNA1 | 3.59e-06 | 1106 | 110 | 17 | M39071 |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_UP | 2.22e-05 | 200 | 110 | 7 | M3689 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 2.40e-05 | 136 | 110 | 6 | MM407 | |
| Coexpression | FAELT_B_CLL_WITH_VH3_21_UP | 3.83e-05 | 45 | 110 | 4 | M15164 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-07 | 185 | 111 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.85e-07 | 189 | 111 | 7 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 198 | 111 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.09e-07 | 200 | 111 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19_Moderate-B_cell|COVID-19_Moderate / disease group, cell group and cell class | 1.53e-06 | 142 | 111 | 6 | 88bb8d9bca66131df4ee7021b88248e146aa7aa6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-06 | 160 | 111 | 6 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.49e-06 | 171 | 111 | 6 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.97e-06 | 174 | 111 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.42e-06 | 182 | 111 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.05e-06 | 185 | 111 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 185 | 111 | 6 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 185 | 111 | 6 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 185 | 111 | 6 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 187 | 111 | 6 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-06 | 188 | 111 | 6 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.97e-06 | 189 | 111 | 6 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-06 | 190 | 111 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 193 | 111 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 193 | 111 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 193 | 111 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.98e-06 | 193 | 111 | 6 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.52e-06 | 195 | 111 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.80e-06 | 196 | 111 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.80e-06 | 196 | 111 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 9.80e-06 | 196 | 111 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 197 | 111 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.01e-05 | 197 | 111 | 6 | 98f0184a09563a544f0c2d4df22c9db2fbc95019 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 198 | 111 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 199 | 111 | 6 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.10e-05 | 200 | 111 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | medial-Endothelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | e889b593c2ae53c42944213ce8672cd886917105 | |
| ToppCell | distal-1-Endothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 8f25b27c10e89cf9d0091bd53c24ce63ed7d6222 | |
| ToppCell | medial-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 70440db2d8be1e29aeb34ea5e8ac72641b5c056f | |
| ToppCell | distal-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 7a99f28670ffb8ece7873d8a9bcd2a3936d0255d | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 200 | 111 | 6 | 90061284a80d29a4ca6078f578e13d32b8cc80e1 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 200 | 111 | 6 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | COVID-19_Moderate-B_cell|World / disease group, cell group and cell class | 2.58e-05 | 139 | 111 | 5 | b93e1da87d44e55d75e8cc1b87c2970645679c01 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.27e-05 | 146 | 111 | 5 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.27e-05 | 146 | 111 | 5 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.05e-05 | 160 | 111 | 5 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.20e-05 | 161 | 111 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.68e-05 | 164 | 111 | 5 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 164 | 111 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 166 | 111 | 5 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-05 | 166 | 111 | 5 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 166 | 111 | 5 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-05 | 166 | 111 | 5 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.37e-05 | 168 | 111 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 172 | 111 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 172 | 111 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 173 | 111 | 5 | 2eb6e9fc3a3654f6f86fbd112e80a18814afd103 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 7.31e-05 | 173 | 111 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 174 | 111 | 5 | 8d6df5938cef542f23259ce471eea1a1afbed03c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 174 | 111 | 5 | 2af54c3427aacfa232e2aca6003b4a8ecb8bba66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 174 | 111 | 5 | eca643b8f5b92aeed5a77c94b4301fd8100f9401 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.72e-05 | 175 | 111 | 5 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.93e-05 | 176 | 111 | 5 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-05 | 176 | 111 | 5 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-05 | 176 | 111 | 5 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 8.15e-05 | 177 | 111 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.37e-05 | 178 | 111 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 178 | 111 | 5 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 182 | 111 | 5 | 63b41b538b26bc899558807fd035e543611f8c52 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.53e-05 | 183 | 111 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.00e-04 | 185 | 111 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 185 | 111 | 5 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 186 | 111 | 5 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 187 | 111 | 5 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 187 | 111 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 187 | 111 | 5 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 187 | 111 | 5 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 187 | 111 | 5 | a63fa3255ad58f3a73c596df99ce9649fdbaeb39 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 187 | 111 | 5 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | droplet-Large_Intestine-COLON:P+D|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 187 | 111 | 5 | b1bb5c48258a9d058614d23001899dbe44857a1f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 187 | 111 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 188 | 111 | 5 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 188 | 111 | 5 | bfd3b4f57785596b2bd2c657e0d2d8b0f40ba36d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.08e-04 | 188 | 111 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.08e-04 | 188 | 111 | 5 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 188 | 111 | 5 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 188 | 111 | 5 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.08e-04 | 188 | 111 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 188 | 111 | 5 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 188 | 111 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.11e-04 | 189 | 111 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 1.11e-04 | 189 | 111 | 5 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.11e-04 | 189 | 111 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 189 | 111 | 5 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.14e-04 | 190 | 111 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 190 | 111 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 191 | 111 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-04 | 192 | 111 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 192 | 111 | 5 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 192 | 111 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.20e-07 | 195 | 109 | 9 | 3124_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.09e-06 | 198 | 109 | 8 | 4762_DN | |
| Disease | plexin-A1 measurement | 3.97e-05 | 3 | 108 | 2 | EFO_0801892 | |
| Disease | cortical surface area measurement | PALD1 ANK3 MYO9B MYT1 PARD3B PSTPIP1 MED13L SMOC2 IRAG1 UBTF RALBP1 PAFAH1B1 PCBP2 BANK1 | 3.98e-04 | 1345 | 108 | 14 | EFO_0010736 |
| Disease | asthma | 4.42e-04 | 751 | 108 | 10 | MONDO_0004979 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 7.27e-04 | 110 | 108 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | post-traumatic stress disorder | 9.01e-04 | 202 | 108 | 5 | EFO_0001358 | |
| Disease | Carcinogenesis | 1.01e-03 | 13 | 108 | 2 | C0596263 | |
| Disease | ovarian neoplasm | 1.51e-03 | 134 | 108 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.64e-03 | 137 | 108 | 4 | C1140680 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.78e-03 | 140 | 108 | 4 | EFO_0001357 | |
| Disease | peak expiratory flow | 2.41e-03 | 498 | 108 | 7 | EFO_0009718 | |
| Disease | Autistic Disorder | 2.77e-03 | 261 | 108 | 5 | C0004352 | |
| Disease | Corneal astigmatism | 2.87e-03 | 77 | 108 | 3 | EFO_1002040 | |
| Disease | schizophrenia (is_implicated_in) | 2.97e-03 | 78 | 108 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Abnormality of refraction | 3.36e-03 | 673 | 108 | 8 | HP_0000539 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRPTSIPPKEETTPY | 616 | Q8NDB2 | |
| PTVPLPSETDGYVAP | 1116 | P04626 | |
| SISYTGPTERPPNEP | 251 | Q53H12 | |
| VLDKDSPVYPGPARP | 6 | P47902 | |
| SSDTQGPKVTYIPPP | 236 | Q9NQI0 | |
| RPEGVYDIPPTCTKP | 256 | Q14511 | |
| GDVPSERPFYPPTLV | 371 | Q8IZ83 | |
| VYDVPPSVEKGLPPS | 286 | P56945 | |
| YDVPPSVSKDVPDGP | 306 | P56945 | |
| TEGFKYPRPSSVPPS | 631 | P54840 | |
| KRAPSPGAYKTATPP | 641 | P54259 | |
| PTSPPTGETERYKGP | 716 | O75078 | |
| PFDGSPKITYSTPPV | 266 | B6SEH9 | |
| KDATPPPVPAERPSY | 2431 | Q8TDJ6 | |
| SVPEPGELKPALRPY | 451 | O43246 | |
| SVESPYSKSGPALPP | 511 | Q9UQB3 | |
| VEIPPSSPNPDGKGY | 1796 | Q9C0F0 | |
| SRPSVPDKPKNPTYG | 301 | P50281 | |
| RKSEPPPETLYDSGA | 351 | Q9Y5P3 | |
| TKFPGLYRTGEPSPP | 36 | Q15311 | |
| PRPPEKYALSGHRSP | 96 | P43034 | |
| KGYAPPPSDPLRTHV | 236 | Q9NWS1 | |
| SEPPPGKEGPLTYRF | 586 | Q9ULE6 | |
| KQERISYTPPESPVP | 11 | P41212 | |
| YPGLPEPSKVTSPVV | 8956 | Q8WXI7 | |
| PPPPSRDLTEAYKTQ | 1386 | Q9Y618 | |
| AKSTGTEPPAPVPYQ | 271 | O43586 | |
| LESPPKGATIPYHPS | 171 | P57723 | |
| PPKGSYPRPTELRVA | 1121 | Q8TEW8 | |
| PSPSKRPYGASPARE | 16 | Q6NXN4 | |
| STDTPYPGSLPPELR | 186 | O60309 | |
| TPVDRSKGPEPSFPT | 1341 | Q7RTP6 | |
| PGVSATPPKSPVYLD | 936 | Q66K74 | |
| YGSEESPEPLPIPTL | 1371 | Q71F56 | |
| SSPPAEAPKPPVYSR | 11 | Q9UJ55 | |
| STDTPYPGSLPPELR | 186 | A6NM11 | |
| STDTPYPGSLPPELR | 186 | A6NMS7 | |
| PSYPPIVTVPKSIDD | 156 | Q96QG7 | |
| PETPLRAEPPSSYKV | 226 | Q9NU53 | |
| SYPAEPREPQESPKI | 991 | Q9P266 | |
| YRKGTTPPRSPEASP | 456 | Q9HDC5 | |
| SSVPPAEGPVYLGKP | 2271 | Q9UPA5 | |
| VPPRYKEPTTDEAPS | 5866 | Q5CZC0 | |
| PFDGSPKITYSTPPV | 266 | B6SEH8 | |
| DPLQYPETTPKGLAP | 286 | Q9Y6F6 | |
| PDPAPDAYRPVGLTK | 766 | O15534 | |
| TGPVEDNEKCYPPPS | 86 | Q9UIW2 | |
| SPPLTTGPPEFERVY | 36 | Q16873 | |
| EEKPPSYRSLDITPG | 506 | Q86SU0 | |
| YERKSGKQGSSPPPP | 891 | O60337 | |
| GPALPSPYSKVTAPR | 1606 | Q9ULI4 | |
| SKTYETPPPSPGLDP | 136 | Q14168 | |
| PSDKIYPPSGSPEEN | 1241 | A7KAX9 | |
| PYRPKPSSSPVIFAG | 181 | Q15366 | |
| PPTEGAYVPGKPTLV | 726 | Q9Y5I3 | |
| EPPPPYSEVLTDTRG | 161 | Q8TB68 | |
| DEPVAAKRPVSPYSG | 346 | Q9NQ84 | |
| DDSTPSILPAPRGYP | 36 | Q96RI0 | |
| VQGEEKYPKTSPPPT | 106 | Q711Q0 | |
| PGYDPDTVASPKPVS | 1336 | Q9ULT8 | |
| PSEPRGIYASERPKS | 151 | Q96B18 | |
| AVPSGPPKYPTAERE | 436 | Q96B18 | |
| PVPVPSYGGEEPVRK | 1881 | Q8N1I0 | |
| TDDYAVPPPRSTKPL | 406 | Q99704 | |
| DLTPPPEVVYKSEPG | 201 | O00341 | |
| SGKVYPTVHTSPPPE | 586 | O43497 | |
| DSPPRQAPRSAPYKG | 426 | Q96S94 | |
| AYIPGKPSPIPEVSE | 3191 | Q12955 | |
| ETGEPYRLSPEPTPL | 306 | Q04637 | |
| AGPSIPPAVSYTKRP | 426 | Q9P0L2 | |
| PGYSPGFRKPPEVVR | 6 | Q9NYP3 | |
| PVPYPGLSTVPSDET | 176 | Q5JT82 | |
| YIKPPVPPASGTHRE | 31 | Q5TBA9 | |
| PNEEPKVATAYRPPA | 436 | Q9BY44 | |
| PTSAYPERKGSPTPG | 871 | Q6ZRV2 | |
| SQTEEERKTPFYPPP | 381 | Q86YT5 | |
| PTSPDYSLDSPGPEK | 111 | O75995 | |
| KYRPEAPGPSVSLSP | 131 | Q9BWG6 | |
| SVYRPRLSKPEEPPS | 26 | Q96LW4 | |
| EPYPSVVDPTDPKTL | 356 | Q2NL67 | |
| EIPYPTEPARAGLPS | 571 | Q96RD6 | |
| SAPYPPLDTPETATG | 491 | Q9NRF2 | |
| PAFPGRAIKSEYPEP | 186 | Q13285 | |
| EPLPPPYSLREVKVS | 171 | Q9NRR2 | |
| EPSKTTGAPIYPGFP | 211 | O76064 | |
| HKPPSVPEEYALTSP | 886 | Q5HYW2 | |
| GLSTPPPPAYESIIK | 216 | Q8N699 | |
| PKINFSGPDYPSIRP | 406 | Q8NA58 | |
| SYGTDESPEPLPIPT | 1321 | Q9UHV7 | |
| RPIHPSKAPNYPTEG | 151 | Q9GZT8 | |
| TKGAEDYPDPPIPHS | 1001 | O94875 | |
| SPAKDAYPETGPDAP | 151 | Q8IZ96 | |
| APPTLPGRDEPYTKQ | 106 | Q14CN2 | |
| DTRDDPYRPAKPVPT | 136 | O14730 | |
| TYLDDHGPPPSKVLP | 86 | Q9Y2C2 | |
| RRSISSPKVPPYPEV | 501 | Q9Y2H5 | |
| GYTPEPARITSPDKP | 291 | P43403 | |
| SSRPPEPQKAPSRPY | 1136 | Q9UDY2 | |
| LPLYPDPSRVPGTKT | 6 | Q6ZSR9 | |
| PLDTVYPAPEKRPSA | 696 | O15027 | |
| YPAPEKRPSARTQGP | 701 | O15027 | |
| GRPIPGTSTRYEQPK | 266 | Q9H3U7 | |
| TYGRPPDSVPVDSFP | 346 | Q7Z7A4 | |
| SVRGKYSDDTPLPTP | 256 | Q92620 | |
| FPKDRSGIETFSPPP | 701 | Q86YV5 | |
| GPRSYPVIPVPSKGS | 376 | Q2VWA4 | |
| YIPEDPTFKPSGPSV | 446 | Q9UBD6 | |
| TSSGGYRPPPRTKEV | 141 | Q8IZN3 | |
| PIAAPLVPYPEKSSE | 81 | Q96LX8 | |
| GASYEPTILGKPPTP | 366 | Q6UX68 | |
| DKFDGRPTKPPPNSY | 291 | P17480 | |
| PSHVKAEPKDSYPGP | 646 | Q68DK2 | |
| SPAIKYRPENTPEPV | 11 | P07947 | |
| YPVPASKRPPLRGVE | 21 | O60682 | |
| GQPPGAKRRYSDPPT | 2131 | Q13459 | |
| PELRGPESPSPKPEY | 326 | Q01538 | |
| PESPSPKPEYSVIVE | 331 | Q01538 |